Postoperative infections after dental implant placement: Variables associated with increased risk of failure by Camps Font, Octavi et al.
Received: 10 January 2018 Revised: 22 March 2018 Accepted: 23 March 2018
DOI: 10.1002/JPER.18-0024
OR IG INAL ART ICLE
Postoperative infections after dental implant placement:
Variables associated with increased risk of failure
Octavi Camps-Font1 Pablo Martín-Fatás1 Adrià Clé-Ovejero1 Rui Figueiredo1
Cosme Gay-Escoda1,2 Eduard Valmaseda-Castellón1
1Oral Surgery and Implantology, Faculty of
Medicine and Health Sciences, University of
Barcelona, Barcelona, Spain
2Oral Surgery and Implantology, Faculty of
Medicine, Efhre International University,
Belize City, Belize
Correspondence





Background:Wound infections after dental implant placement are a rare finding that
might lead to early implant failure. However, the available information on this topic
is scarce.
Methods: This retrospective cohort study was conducted to determine factors that
may increase the failure rate of dental implants that presented a postoperative infec-
tion during the osseointegration period. Postoperative infections were defined as the
presence of pus or fistula in the surgical area, with pain or tenderness, swelling, red-
ness, and heat or fever, before prosthetic loading. A bivariate and multivariate analysis
of the data using Cox proportional-hazards regression was performed to detect prog-
nostic factors for implant failure in patients that suffer infections.
Results: The patient-based prevalence of postoperative infections after implant place-
ment was 2.80% (95% confidence interval (95%CI): 2.04% to 3.83%). Thirty-three
out of 37 (89.19%) patients with infections had to be surgically retreated because of
antibiotic failure and 65% of the infected implants were removed. The bivariate anal-
ysis showed a significant association between implant failure and the collar surface
(HR: 3.12; 95% CI: 1.16 to 8.41; P = 0.014). Cox proportional-hazards regression
indicated that rough-surfaced collars increased 2.35 times the likelihood of failure
(95% CI: 0.87 to 6.37; P = 0.071).
Conclusions: The survival of implants placed in the maxilla, with smooth collar, and
late-onset of infection was higher than those placed in the mandible, with a rough
collar and early onset of infection. In general, signs of infection after dental implant
placement compromises the survival rate of the affected fixtures.
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1 INTRODUCTION
Over recent decades, the use of dental implants for oral reha-
bilitation has been proven to be a reliable therapeutic option
in a broad variety of scenarios, due to its positive long-term
clinical results.1,2 However, both short- and long-term com-
plications may arise.3
Postoperative infections are considered a rare compli-
cation, with a prevalence ranging from 1.6% to 11.5%.4–12
They usually occur within the first month after dental implant
placement.4 Changes in the oral flora caused by postoperative
short-duration systemic and topical antibacterial therapy
could also favor the development of opportunistic infections.
Nonetheless, as with any biomaterial-centered infection, such
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complications do not respond to antibiotics and frequently
persist until the implant is removed.13,14 Accordingly,
postoperative infections have been suggested as a risk factor
for osseointegration,15,16 increasing the risk of early failure
almost 80-fold.17
Patients undergoing dental implant placement in the
mandible with submerged healing seem to be more prone
to develop these postoperative infections.17 However, very
limited information is available on the survival of infected
implants and on the main prognostic factors for early failure.
Therefore, the aim of the present study was to determine fac-
tors that may increase the failure rate of dental implants that
have presented a postoperative infection during the osseointe-
gration period.
2 MATERIALS AND METHODS
A retrospective cohort study was conducted in a total of
1,322 outpatients (2,673 implants) who were treated consec-
utively between January 2004 and October 2015 through the
Oral Surgery and Implantology Master's degree program of
the University of Barcelona. The study design followed the
STROBE guidelines for cohort studies.18 The protocol com-
plied with the Helsinki Declaration and was approved by the
Ethical Committee for Clinical Research (CEIC) of the Dental
Hospital of the University of Barcelona (Spain).
Patients were given full information about the surgical pro-
cedures and treatment alternatives, and informed consent was
obtained in all cases. The preoperative analysis included clin-
ical and radiographic examinations (with panoramic radio-
graphs or computed tomography).
The exclusion criteria were general contraindications to
implant surgery, such as an American Society of Anes-
thesiologists (ASA) health status score19 higher than 3,
immunosuppression, bleeding disorders, active treatment of
malignancy, drug abuse, psychiatric illness, and intravenous
bisphosphonate use.20,21 Patients under 18 years of age were
also excluded.
Patients with active periodontal disease were treated prior
to the study in accordance with the American Academy of
Periodontology guidelines.22
Postoperative infections were defined as the presence of
purulent drainage (pus) or a fistula in the operated region,
with pain or tenderness, localized swelling, redness, or heat
or fever (> 38◦C), before prosthetic loading.23 If the postop-
erative infection involved several implants, then one of them
was selected using a random-numbers table based on the posi-
tion of the implant according to the double-digit FDI World
Dental Federation classification.
To avoid misclassification bias, any of the following cir-
cumstances were excluded from the analysis: incomplete clin-
ical records, dental implants placed in previous failure sites,
patients who required guided bone regeneration procedures
or procedures involving non-conventional prosthetic loading
(the inclusion criteria were ≥3 months in the mandible and
4 months in the maxilla after implant placement).
Early implant failure was defined as the absence or removal
of the dental implant at any point in time after its placement
and before the final restoration was placed.16
The patients’ records were followed up through to pros-
thetic loading. The follow-up time was defined as the time
from placement to failure or to prosthetic abutment connec-
tion, whichever happened first.
2.1 Surgical procedure
Implants were placed under local anesthesia, generally with
articaine in a 4% solution with epinephrine 1:100,000,∗ by
third-year fellows of the Master's degree program in Oral
Surgery and Implantology. The surgical technique employed
has been described thoroughly in a previous report.4 Accord-
ing to our protocol, implants rough surface was totally covered
by bone. If the insertion torque was higher than 15 N⋅cm2, a
healing abutment was placed. The flaps were usually reposi-
tioned with 4-0 polyamide† sutures. The suture was removed
7 to 15 days after surgery.
After the operation, an antibiotic (usually amoxicillin
750 mg‡ orally every 8 hours for 7 days), a non-steroidal anti-
inflammatory drug (usually ibuprofen 600 mg§ orally every
8 hours for 4 to 5 days), an analgesic (usually paracetamol
1 g¶ orally every 8 hours for 3 to 4 days), and a mouthrinse
(0.12% chlorhexidine digluconate# 15 mL every 12 hours for
15 days) were prescribed.
Postoperative and prescribed drug use instructions were
explained and were handed to the patient on a sheet of paper.
Patient compliance was not specifically assessed.
2.2 Treatment of the postoperative infection
After infection onset, an antibiotic was prescribed for
7 days (usually amoxicillin with potassium clavulanate or
clindamycin) and the patients were instructed to perform
chlorhexidine digluconate mouthrinses. If this therapy was
insufficient to control the infection, another antimicrobial was
prescribed and a surgical procedure consisting in implant
removal (if the implant had mobility or advance bone loss),
second stage surgery or mechanical debridement with plastic
curets was performed.
∗ Artinibsa; Inibsa Dental, Lliçà de Vall, Spain
† Supramid; Aragó, Barcelona, Spain
‡ Clamoxyl; GlaxoSmithKline, Madrid, Spain
§ Algiasdin; Esteve, Barcelona, Spain
¶ Gelocatil; Gelos, Barcelona, Spain
# Clorhexidina Lacer; Lacer, Barcelona, Spain
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2.3 Data sampling
A single trained researcher (OCF) examined all the clin-
ical records. The following data were retrieved: date of
birth, gender, patient health status based on the ASA Phys-
ical Status Classification System (ASA category 1 or ASA
category >1),19 smoking habit (non-smoker or smoker),
periodontal disease (healthy or periodontally compromised),
implant manufacturer, implant surface (non-anodized or
anodized), implant collar (smooth or rough surface), location
(maxilla ormandible), position (anterior or posterior), implant
placement timing (≤8 or>8 weeks after tooth extraction), pri-
mary stability (insertion torque higher than 15 N⋅cm2), sub-
merged or non-submerged healing, surgeon who performed
the operation and the postoperative follow-up appointments,
and final outcome (survival or early failure). After infection
diagnosis, additional data were also recorded: antibiotic pre-
scribed, treatment duration, and need for an additional sur-
gical procedure (none, surgical debridement, second stage
surgery or implant removal). The dates of implant placement,
infection diagnosis, infection resolution, and last follow-up
were also recorded.
2.4 Statistical analysis
The sample size calculationwas based on the assumptions that
54.5% (SD: 0.50) of postoperative infections lead to implant
failure4 and that the development of infection in implants with
a rough-surfaced collar increases the risk of early implant fail-
ure at least 3-fold. Considering a coefficient of determination
(R2) of 0.25 (implant collar surface variable), an 𝛼 risk of
0.05 and a power of 80%, 35 patients with an infection were
required.
The statistical analysis was carried out with Stata14.∗
The subjects’ characteristics were presented as absolute
and relative frequencies for categorical outcomes. Normality
of scale variables (patient age and time from implant place-
ment to infection onset) was explored using the Shapiro-Wilk
test and through the visual analysis of the P-P plot and box
plot. Where normality was rejected, the interquartile range
(IQR) and median were calculated. Where distribution was
compatible with normality, the mean and standard deviation
(SD) were used.
Cumulative survival rates were calculated using the
Kaplan-Meier method. Univariate analyses using the log-rank
and univariate Cox proportional-hazards regression for con-
tinuous variables were performed to identify the associa-
tion between each categorical and continuous covariate with
implant survival, respectively. Hazard functions (h) and haz-
ard ratios (HR) with 95% confidence intervals (95% CI) were
calculated for each covariate. Odds ratio (OR) with 95% CI
∗ StataCorp, College Station, TX
F IGURE 1 Flowchart of participants in the present study
was estimated to determine the influence of periodontal status
on the risk of postoperative infection, selecting randomly one
control (i.e. patients who underwent the same surgical pro-
cedure within the above-mentioned time frame, but did not
develop infection during the postoperative period) for each
infected patient. The level of significance was set at P < 0.05.
A multivariate analysis was performed using a Cox
proportional-hazards model to assess the contribution of each
of the predictive variables and to construct a predictive model
of postoperative infection resolution. Based on all the possi-
ble subsets obtained by combining the maximum model terms
(i.e. all independent covariates which had a P value < 0.30
in the bivariate analysis), the most parsimonious model with
the highest maximum predictive power (Harrell's c statistic)
was selected. The predictive power of the selected survival
model was compared to that of the maximum model to verify
that there were no differences between them.24 Goodness of
fit of the data was assessed by plotting the cumulative haz-
ard function of Cox-Snell residuals. The Cox proportional-
hazards regression equation was used to calculate the adjusted
HR of the predictive variables with a 95% CI.
3 RESULTS
The 1,322 patients who met the inclusion criteria received
2,673 implants (Figure 1).
Thirty-seven postoperative infections (37 patients) were
recorded. The patient- and implant-based prevalence was
2.80% (95% CI: 2.04% to 3.83%) and 1.38% (95% CI: 1.01%
to 1.90%), respectively. Tables 1 and 2 show the main demo-
graphic, surgical, and postoperative variables of the sample.
The data were not affected by any loss to follow-up. The
study time ranged from 19 to 208 days with a median of
55 days (IQR: 111 days), during which 24 of the infected
implants (64.9%) were removed. Nine patients who overcame
the postoperative infection required an additional surgical pro-
cedure consisting of second stage surgery (if the implant was
submerged: six cases, 16.22%) or mechanical debridement
with plastic curettes (three cases, 8.11%).
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TABLE 1 Results of the categorical variables
Variables No. (%) Failure risk (h) HR (95%CI) Bivariate (P)
Sex
Female 18 (48.65) 12/18 (0.93) 1 0.690
Male 19 (51.35) 12/19 (1.09) 1.18 (0.53 to 2.62)
ASA Category
ASA category >1 17 (45.95) 11/17 (0.92) 1 0.686
ASA category 1 20 (54.05) 13/20 (1.09) 1.18 (0.53 to 2.64)
Smoking habit
Non-smoker 28 (75.68) 18/28 (0.98) 1 0.851
Smoker 9 (24.32) 6/9 (1.07) 1.09 (0.43 to 2.76)
Periodontal status
Compromised 24 (64.86) 15/24 (0.91) 1 0.494
Healthy 13 (35.14) 9/13 (1.22) 1.34 (0.59 to 3.07)
Location
Maxilla 11 (29.73) 4/11 (0.51) 1 0.042a
Mandible 26 (70.27) 20/26 (1.43) 2.81 (1.02 to 8.40)
Position
Anterior 14 (37.84) 8/14 (0.96) 1 0.898
Posterior 23 (62.16) 16/23 (1.02) 1.06 (0.45 to 2.47)
Implant placement timing
>8 weeks 36 (97.30) 23/36 (0.98) 1 0.311
≤8 weeks 1 (2.70) 1/1 (3.45) 3.51 (0.44 to 27.71)
Implant manufacturer
Implant 1b 9 (24.32) 3/9 (0.44) 1 0.093
Implant 2c 22 (59.46) 16/22 (1.45) 3.26 (0.95 to 11.25)
Implant 3d 4 (10.81) 4/4 (2.45) 6.52 (0.99 to 36.34)
Implant 4e 2 (5.41) 1/2 (0.84) 1.90 (0.20 to 18.32)
Implant surface
Non-anodized 15 (40.54) 8/15 (0.75) 1 0.209
Anodized 22 (59.46) 16/22 (1.29) 1.73 (0.74 to 4.05)
Implant collar
Smooth 13 (35.14) 5/13 (0.53) 1 0.014a
Rough 24 (64.86) 19/24 (1.66) 3.12 (1.16 to 8.41)
Primary stability
No 7 (18.92) 3/7 (0.53) 1 0.139
Yes 30 (81.08) 21/30 (1.23) 2.30 (0.68 to 7.77)
Healing
Submerged 33 (89.19) 21/33 (0.97) 1 0.683
Non-submerged 4 (10.81) 3/4 (1.26) 1.30 (0.39 to 4.36)
Antibiotic prescribed
Azithromycin 2 (5.41) 1/2 (0.64) 1 0.506
Amoxicillin 7 (18.92) 4/7 (0.91) 1.42 (0.16 to 12.76)
Amoxicillin-Clavulanate 15 (40.54) 11/15 (1.15) 1.79 (0.23 to 13.89)
Clindamycin 12 (32.43) 7/12 (0.94) 1.46 (0.18 to 11.88)
Ciprofloxacin 1 (2.70) 1/1 (11.59) 18.06 (0.92 to 354.13)
aIn the bivariate analysis, mandible location and rough implant collar were significantly associated with infections (P < 0.05).
bPhibo, Sentmenat, Spain.
cNobel Biocare, Kloten, Switzerland.
dDENTSPLY Implants, Mölndal, Sweden.
eStraumann AG, Basel, Switzerland.
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TABLE 2 Results of the scale variables
Variables
Mean (SD) or
median (IQR) HR (95%CI)
Bivariate
(P)




4.14 (4.43)c 1.12 (1.02 to 1.22) 0.005a
Antibiotic duration 10 (8)c 0.93 (0.85 to 1.01) 0.057
aIn the bivariate analysis, time from implant placement to infection was
significantly associated with infections (P < 0.05).
bMean (SD).
cMedian (IQR).
Overall, the cumulative survival rate was 33.45% (95% CI:
18.50% to 49.12%) at 208 days after dental implant placement
(Figure 2A). Univariate analysis showed a significant associa-
tion between implant failure and time from implant placement
to postoperative infection (HR: 1.12; 95% CI: 1.02 to 1.22;
P = 0.005), implant collar surface (HR: 3.12; 95% CI: 1.16 to
8.41; P = 0.014) and location of the infected dental implant
(HR: 2.81; 95% CI: 1.02 to 8.40; P = 0.042) (Tables 1 and
2). The survival curves for maxillary location, smooth implant
collar, and late-onset infectionwere higher than for their coun-
terpart groups (Figures 2B through 2D).
TABLE 3 Adjusted hazard ratio (HR) of the variables included in






Rough implant collar 2.35 (0.87 to 6.37) 0.071
Time from implant
to infection
1.11 (1.00 to 1.22) 0.023
Twenty-four infected patients (64.86%) and 21 controls
(56.76%) were periodontally compromised (OR = 1.41; 95%
CI, 0.56 to 3.56; P = 0.475).
The final Cox proportional-hazards regression model
included the following independent variables: implant col-
lar surface and time from implant placement to postoperative
infection onset (Table 3). Each week earlier in the appear-
ance of postoperative infection multiplied the adjusted risk of
failure by 1.11 (95% CI: 1.00 to 1.22; P = 0.023). Addition-
ally, dental implants with rough-surfaced collars increased the
adjusted risk of failure by 2.35 times compared to those with
a smooth collar surface (95% CI: 0.87 to 6.37; P = 0.071).
The change in the likelihood ratio of the Cox proportional-
hazards regression model was significant (𝜒2 = 11.21; df= 2;
P = 0.004). Despite the small number of cases, the hazard
F IGURE 2 Kaplan-Meier survival curves for implant survival. A) overall outcome, B) by implant location (maxilla/mandible), C) by implant
collar surface (smooth/rough) and D) by time from dental implant placement to infection (4 weeks or earlier/over 4 weeks after implant placement).
Vertical lines indicate survival from infection, followed by prosthetic loading
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F IGURE 3 Predicted probability of survival of three hypothetical
patients with average, favorable and unfavorable characteristics. Type A
(most unfavorable) is a subject with a rough-collared implant who
develops an infection 2.9 weeks (the value that defines the first quartile
of this variable) after implant placement. Type B (most favorable) is an
individual with a smooth-collared implant who develops an infection
after 7.3 weeks (the value that defines the third quartile of this
variable)
function of Cox-Snell residuals showed a good fit with the
data. The assumptions of the model were fulfilled: none of the
variables included in the finalmodel had a time-varying effect,
either collectively or individually (P = 0.055 and P = 0.445
for time from implant placement to postoperative infection
onset and implant collar, respectively), thus supporting the
assumption of proportional hazard, and there was a log-lineal
relation (P = 0.786).
Harrell's c statistic was 0.78 (95% CI: 0.65 to 0.91), show-
ing good predictive power. The loss of predictive power
between the model selected and the maximal survival model
was not significant (−2.07%; 95% CI: −8.99% to 4.85%;
P = 0.538). Figure 3 shows the predicted probability of sur-
vival of three hypothetical patients with different patterns of
characteristics (i.e. unfavorable, average and favorable cases).
Similarly, supplementary Table S1 in the online Journal of
Periodontology depicts the predicted probability of survival
at the end of the follow-up period (208 days) for several
clinical scenarios.
4 DISCUSSION
This study aimed to identify some of the prognostic factors for
failure in dental implants that presented postoperative infec-
tions. Prognostic research provides information to patients
about possible outcomes, identifies risk groups for stratified
management, and helps target specific prognostic factors for
modification.25 Several reports have addressed the prevalence
and described some of the clinical features and risk factors
for postoperative infections.4–12,17 However, to the best of
the authors’ knowledge this cohort study adds useful new
information to the literature, since it identifies which patients
and implants are associated with a higher risk of failure after
a postoperative infection. Thus, this study provides data that
might help clinicians to decide whether to treat the infection
or to remove the implant directly due to its poor prognosis.
It is also interesting to consider a previous report by Camps-
Font et al.4 which shows that loaded implants that have previ-
ously suffered a postoperative infection have a poor outcome
in the short-term (a success rate of 50% after a mean follow-up
period of 43 months).
The main limitations of the present study are its retrospec-
tive nature, which did not allow the recording and analysis of
all possible potential prognostic factors. In this sense, future
research should address the role of covariates related with the
etiopathogenesis of early implant failure such as bone over-
heating of the surgical site,26 bone quality and surgeons’ expe-
rience. Another limitation of the study is the criteria used to
define infection, based mostly on clinical observations. How-
ever, few conditions other than infections can be considered
in the differential diagnosis of patients who start having pain
a few days after implant placement. Some methods, such as
determining C-reactive protein levels, could help to detect
infections in a more objective way.27 Also, it should be inter-
esting to evaluate in the future, if having a preoperative cone-
beam computed tomography (CBCT) decreases the rate of
complications and of postoperative infection. This variable
could not be assessed in the present cohort because the crite-
ria used to perform a CBCT before surgery varied throughout
the years (after 2011 almost all patients included in the study
had a CBCT available, whereas that was not the case for cases
included in the initial years of the cohort).
The authors decided to exclude implants that required
simultaneous bone grafting techniques because these
procedures can increase the risk of infection, especially when
membranes are exposed due to inadequate wound closure.
Although the prevalence per patient of postoperative infec-
tions when systemic antibiotics are administered varies con-
siderably across published studies, Esposito et al.28 reported
a weighted rate of 2.3% (95% CI: 0.4% to 4.1%). These num-
bers are quite similar to those reported in this study. In con-
trast, the small number of participants in some reports,9–12
the absence of standardized diagnostic criteria, the different
research designs and the diversity of the demographic charac-
teristics of the samples could partially explain the wide range
of infection rates.
A single preoperative administration of antibiotics seems
to reduce the failure rate of dental implants placed under
ordinary conditions. However, this single dose does not
seem to have any effect on prevention of postoperative
infections. In fact, a recent meta-analysis reported no
statistically-significant differences regarding infection preva-
lence when antibiotics were administered (5.9% versus 7.0%.
P = 0.39).28
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The cumulative survival rate is the probability that an
implant will survive to a particular point in time. In this study,
the number of implants that failed over the osseointegration
period numbered 24 out of a total of 37 cases of postoperative
infection, yielding a cumulative survival rate of 33.5% at the
end of the follow-up. This finding is in accordance with papers
that have considered postoperative infections one of the main
risk factors for early implant failure.5,6,10,15–17
A recent study by the present research group revealed that
dental implants placed in the mandible are more prone to
infectious complications.17 The bivariate analyses performed
in the present study also identified a statistically significant
association between mandibular location and implant failure
(Table 1 and Figure 2D). The reason might be that the rela-
tively poor blood supply and macro- and micro-architecture
(thick cortical plates and small medullary spaces) of the
mandible might hamper the already complex management of
this complication. However, this variable was not included in
the final Cox proportional-hazards regression model, as other
variables could act as confounders. Indeed, the relationship
between implant location and failure varied when stratified by
primary stability (𝜒2 = 2.13; df = 1; P = 0.145), which might
suggest that primary stability could be a confounding factor.
The previous history of periodontitis was not related to an
increased risk of developing a postoperative infection neither
a higher probability of early failure in case of suffering this
complication. These findings are consistent with a previous
report of the present research group17 and could be partially
explained because all patients with active periodontal disease
were treated before implant placement.22
Traditionally, it has been suggested that early signs of
infection after dental implant placement may be much more
critical than if the same complication occurs later, because
the process of osseointegration can be disturbed.29 Late
superficial postoperative infections of soft tissues are gener-
ally uncomplicated and can sometimes be attributed to rem-
nants of suture material, to insufficient tightening of the cover
screw or to excessive pressure of the dentures on the underly-
ing mucosa.30 The present results agree with previous publi-
cations, since late-onset postoperative infections were associ-
ated with a better prognosis. Indeed, each week earlier in the
appearance of postoperative infection multiplied the adjusted
risk of failure by 1.11. Besides, more than three-quarters
of the postoperative infections which led to implant failure
occurred during the first 2 months after placement. Never-
theless, the fact that this complication has a delayed onset (it
generally occurs 1 month after the surgical procedure), prob-
ably due to the postoperative use of antibiotics and antiseptic
mouthrinses, highlights the importance of establishing a strict
patient follow-up protocol during the first postoperative weeks
to initiate early treatment if required.
Generally, rough implant surfaces enhance initial adhe-
sion, attachment, and colonization by bacteria and favor
plaque formation. Zaugg et al.31 concluded that rougher sur-
faces increase bacterial adhesion and make biofilm removal
more difficult. Consequently, when some degree of bone loss
occurs these surfaces might favor the onset and progression
of peri-implant diseases.32,33 The present results suggest that
implants with rough-surfaced collars had a worse progno-
sis even after pharmacological treatment of the postoperative
infection. Indeed, these implants had an adjusted 2.35 times
higher probability of early implant failure when compared
with smooth-surfaced collar fixtures. In future, prospective
studies should be conducted to confirm this relation.
Smoking has been well-established as a risk factor
for periodontitis and peri-implant diseases.34,35 Moreover,
several studies have shown that tobacco reduces implant
survival.36–39 Surprisingly, this association was not found in
the present study. In the authors’ opinion, this could be due to
the fact that smoking was recorded as a dichotomous variable
because of the small number of cases. Moreover, the amount
of tobacco was self-reported, leading to possible recall bias.
The impact of systemic diseases on the outcome of implant
therapy remains unclear. Although some investigators have
reported higher complication rates in medically compromised
patients,40 others, in accordance with the present observa-
tions, have suggested that some conditions do not seem to
influence the treatment outcomes.41 Nevertheless, it seems
reasonable to assume that the severity of systemic diseases
can be far more critical than the disorder itself. Therefore, a
strict preoperative assessment allowing adequate diagnosis
and management of any systemic disorder is mandatory
because it can lower the complication rates of the implant
therapy.
It has been claimed that some anaerobes can attach directly
to an inert titanium surface, colonize it and subsequently
lead to infection of the peri-implant tissues.42,43 Accord-
ingly, amoxicillin plus potassium clavulanate, clindamycin,
or metronidazole should be three of the most suitable antibi-
otic treatments for this complication. However, none of the
antibiotics proved more effective than any of the others in
the present sample (Table 1). Indeed, 33 out of 37 (89.19%)
patients with infections had to be surgically retreated because
of antibiotic therapy failure. This stresses the importance of
performing a study to identify the bacteria involved and their
susceptibility to commonly used antibiotics, to determine the
most adequate drugs to treat such infections. In addition, when
systemic antibiotics are prescribed empirically without micro-
biological monitoring, the appearance of superinfections and
the overgrowth of opportunistic pathogens difficult to eradi-
cate can occur.44 Hence, local application of the antibiotics
might be specially indicated in this complication, since sys-
temic administration might produce low bioavailability of
the drug in the infected region. A more effective therapeu-
tic approach might lead to improvements in the survival and
success rates of these implants.
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5 CONCLUSIONS
Patients that suffer a postoperative infection after dental
implant placement have a poor prognosis, with a cumulative
survival rate of 33.5%. Surgical therapy was required to treat
89% of infections since systemic antibiotic therapy was insuf-
ficient in most cases. Implants with a rough-surfaced collar
where an early postoperative infection develops seem to be
more prone to suffer early failure of the fixture.
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